Insider Trading & Ownership - Spyre Therapeutics Inc. (SYRE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Spyre Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-25
Purchase
2022-08-25
7:37 pm
Aeglea BioTherapeutics Inc.AGLESouza Marcio
Director
90,000$0.5608$50,47290,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-15
Option Award
2024-02-20
9:21 pm
N/A
N/A
Spyre Therapeutics Inc.SYRETurtle Cameron
Chief Executive Officer
400$9.82746,907
(Direct)
View
2024-02-01
Option Award
2024-02-05
5:29 pm
N/A
2034-02-01
Spyre Therapeutics Inc.SYREMcKenna Mark C.
Director
40,000$040,000
(Direct)
View

Ownership
2024-02-05
5:25 pm
N/A
2033-11-22
Spyre Therapeutics Inc.SYREMcKenna Mark C.
Director
0$0477,000
(Direct)
View
2024-02-01
Option Award
2024-02-02
8:31 pm
N/A
2034-02-01
Spyre Therapeutics Inc.SYRETurtle Cameron
Chief Executive Officer
277,750$0277,750
(Direct)
View
2024-02-01
Option Award
2024-02-02
8:27 pm
N/A
2034-02-01
Spyre Therapeutics Inc.SYREBurrows Scott L
Chief Financial Officer
70,000$070,000
(Direct)
View
2024-02-01
Option Award
2024-02-02
8:23 pm
N/A
2034-02-01
Spyre Therapeutics Inc.SYREKing-Jones Heidy
See Remarks
63,000$063,000
(Direct)
View
2023-12-29
Other
2023-12-29
5:00 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,841,518$05,485,719
(Indirect)
View
2023-12-22
Option Award
2023-12-22
6:00 pm
N/A
N/A
Spyre Therapeutics Inc.SYREBurrows Scott L
Chief Financial Officer
134,953$0134,953
(Direct)
View
2023-12-07
Option Award
2023-12-11
5:41 pm
N/A
N/A
Spyre Therapeutics Inc.SYREFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
16,667$60016,667
(Indirect)
View
2023-11-24
Conversion(A)
2023-12-08
4:07 pm
N/A
N/A
Spyre Therapeutics Inc.SYREAlbers Jeffrey W.
Director
35,219$084,360
(Indirect)
View
2023-11-22
Option Award(A)
2023-12-08
4:07 pm
N/A
2033-11-22
Spyre Therapeutics Inc.SYREAlbers Jeffrey W.
Director
50,000$084,360
(Direct)
View

Ownership(A)
2023-12-08
4:03 pm
N/A
N/A
Spyre Therapeutics Inc.SYREAlbers Jeffrey W.
Director
0$034,360
(Indirect)
View
2023-11-24
Conversion
2023-11-28
4:05 pm
N/A
N/A
Spyre Therapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
3,521,367$04,250,938
(Indirect)
View
2023-11-22
Option Award
2023-11-27
4:36 pm
N/A
2033-11-22
Spyre Therapeutics Inc.AGLEAlbers Jeffrey W.
Director
50,000$050,000
(Direct)
View
2023-11-22
Option Award
2023-11-27
4:33 pm
N/A
2033-11-22
Spyre Therapeutics Inc.AGLEStelzer Laurie
Director
50,000$050,000
(Direct)
View
2023-11-24
Conversion
2023-11-27
4:25 pm
N/A
N/A
Spyre Therapeutics Inc.AGLETurtle Cameron
Chief Executive Officer
741,526$01,120,507
(Direct)
View
2023-11-22
Option Award
2023-11-27
4:25 pm
N/A
2033-11-22
Spyre Therapeutics Inc.AGLETurtle Cameron
Chief Executive Officer
374,000$01,120,507
(Direct)
View
2023-09-01
Option Award
2023-09-05
4:15 pm
N/A
2033-09-01
Aeglea BioTherapeutics Inc.AGLEKing-Jones Heidy
See Remarks
13,495,255$013,495,255
(Direct)
View
2023-09-01
Option Award
2023-09-05
4:10 pm
N/A
2033-09-01
Aeglea BioTherapeutics Inc.AGLEBurrows Scott L
Chief Financial Officer
10,121,441$010,121,441
(Direct)
View

Ownership
2023-06-30
5:32 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEFairmount Funds Management LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
Fairmount Healthcare Co-Invest L.P.
Kiselak Tomas
Harwin Peter Evan
Director
10% Owner
0$0536,284,540
(Indirect)
View

Ownership
2023-06-30
5:14 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLETurtle Cameron
Chief Operating Officer
0$065,959,896
(Direct)
View

Ownership
2023-06-30
5:13 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLEHENDERSON MICHAEL THOMAS
Director
0$01,950,000
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:34 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
President and CFO
19,787,969$019,787,969
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:33 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLECox Russell J.
Director
1,950,000$01,950,000
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:32 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLEMagovcevic-Liebisch Ivana
Director
1,950,000$01,950,000
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:31 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLESmith Hunter C
Director
1,950,000$01,950,000
(Direct)
View
2023-06-22
Option Award
2023-06-30
4:30 pm
N/A
2033-06-22
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
1,950,000$01,950,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:25 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
550,000$0550,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:24 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
General Counsel
500,000$0500,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:22 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEHanley Jr. Michael Conick
Chief Business Officer
500,000$0500,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:20 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
640,000$0640,000
(Direct)
View
2022-11-14
Option Award
2023-01-27
6:20 pm
N/A
2032-11-13
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
25,000$025,000
(Direct)
View

Ownership
2023-01-27
6:18 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
0$0140,250
(Direct)
View
2022-11-29
Option Award
2022-12-01
8:47 pm
N/A
2032-11-28
Aeglea BioTherapeutics Inc.AGLEGoldberg Jeff Marc
President and CEO
1,884,838$01,884,838
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:39 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
130,000$0130,000
(Direct)
View

Ownership
2022-08-25
7:37 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
0$0219,000
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next